Clinical Trial Update: Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on diltiazem for preclinical hypertrophic cardiomyopathy in Phase 2/3, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• Diltiazem (diltiazem)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Hypertrophic Cardiomyopathy | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-04-07